Register Login

KAZIA THERAPEUTICS LTD (KZIA)

SymbolKZIA
NameKAZIA THERAPEUTICS LTD
SectorHEALTH CARE
RegionOceania
IndustryPharmaceutical Preparations
AddressTHREE INTERNATIONAL TOWERS LEVEL 24,, SYDNEY NSW, None 2000
Telephone01161298780088
Fax—
Email—
Websitehttps://www.kaziatherapeutics.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001075880
Description

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.

Additional info from NASDAQ:
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.

2026-06-23 22:47

Levine James E. 🟢 acquired 200.0K shares (1 derivative) of KAZIA THERAPEUTICS LTD (KZIA) at $13.86 ($2.8M) Transaction Date: Jun 19, 2026 | Filing ID: 071231

Read more
2026-06-23 22:47

Rao Sudha 🟢 acquired 250.0K shares (1 derivative) of KAZIA THERAPEUTICS LTD (KZIA) at $18.48 ($4.6M) Transaction Date: Jun 19, 2026 | Filing ID: 071230

Read more
2026-06-15 19:53

New Form 3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-06-15 <b>AccNo:</b> 0001213900-26-068952 <b>Size:</b> 10 KB

Read more
2026-06-03 21:20

New Form 3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-06-03 <b>AccNo:</b> 0001193125-26-256067 <b>Size:</b> 19 KB

Read more
2026-06-02 11:30

Kazia Therapeutics Appoints James Levine as Chief Financial Officer

Read more
2026-05-27 11:32

New Form SCHEDULE 13G/A - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-05-27 <b>AccNo:</b> 0000921895-26-001482 <b>Size:</b> 7 KB

Read more
2026-05-26 09:05

New Form 424B3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-05-26 <b>AccNo:</b> 0001213900-26-060788 <b>Size:</b> 41 KB

Read more
2026-05-26 09:04

New Form 424B3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-05-26 <b>AccNo:</b> 0001213900-26-060785 <b>Size:</b> 41 KB

Read more
2026-05-26 09:03

New Form 424B3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-05-26 <b>AccNo:</b> 0001213900-26-060784 <b>Size:</b> 40 KB

Read more
2026-05-26 09:02

New Form 424B3 - KAZIA THERAPEUTICS LTD <b>Filed:</b> 2026-05-26 <b>AccNo:</b> 0001213900-26-060782 <b>Size:</b> 40 KB

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT04192981 GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brai… Phase1 Brain Metastases Active_Not_Recruiting 2019-12-06 2026-12-01 ClinicalTrials.gov
Total clinical trials: 1
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
whole brain radiation therapy radiation Drug Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
GDC-0084 Other Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
whole brain radiation therapy radiation Drug Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
GDC-0084 Other Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
whole brain radiation therapy radiation Drug Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
GDC-0084 Other Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
whole brain radiation therapy radiation Drug Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
GDC-0084 Other Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
whole brain radiation therapy radiation Drug Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
GDC-0084 Other Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
whole brain radiation therapy radiation Drug Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
GDC-0084 Other Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
whole brain radiation therapy radiation Drug Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
GDC-0084 Other Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
whole brain radiation therapy radiation Drug Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
GDC-0084 Other Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
whole brain radiation therapy radiation Drug Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
GDC-0084 Other Phase PHASE1 Brain Metastases ACTIVE_NOT_RECRUITING NCT04192981
Total products: 18